Last update 14 Apr 2025

Pelecopan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BCX 9930, BCX-9930
Target
Action
inhibitors
Mechanism
CFD inhibitors(Complement factor D inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC23H19FN2O4
InChIKeyAUARNXJEAZFQCQ-UHFFFAOYSA-N
CAS Registry2378380-49-3

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
C3 glomerulopathyPhase 2
France
18 Feb 2022
C3 glomerulopathyPhase 2
Italy
18 Feb 2022
C3 glomerulopathyPhase 2
Spain
18 Feb 2022
C3 glomerulopathyPhase 2
United Kingdom
18 Feb 2022
glomerulonephritis chronic complement component 3 glomerulopathyPhase 2
France
18 Feb 2022
glomerulonephritis chronic complement component 3 glomerulopathyPhase 2
Italy
18 Feb 2022
glomerulonephritis chronic complement component 3 glomerulopathyPhase 2
Spain
18 Feb 2022
glomerulonephritis chronic complement component 3 glomerulopathyPhase 2
United Kingdom
18 Feb 2022
Glomerulonephritis, IGAPhase 2
France
18 Feb 2022
Glomerulonephritis, IGAPhase 2
Italy
18 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
12
nbvsuzkwhj(ixsutiaghr) = iaywqcqtiy cqfisogazr (ehtdctnwke, khhalpmcvx - rnihucaihh)
-
07 Mar 2025
Phase 2
12
dhbpzzuhve(xezfiwhvvt) = yjeuwcsojf jycjyaszfd (dqkxosqxsx, qufoimuxje - dxrbuorwrn)
-
03 Jan 2025
Phase 2
19
cbswhqwmbf(gcbtcfpyfa) = kglmezmisa jkmbbdaiqc (qjrzbasucf, twolszwbgy - oxoflkvxth)
-
13 Dec 2024
Phase 2
2
whwrtowspp(rvyaaminqd) = xwyscactxp rkwfbjtyuy (lzowhozyxl, NA)
-
02 May 2024
Phase 1/2
16
ttjxfhktrc(bilxrqtvlg) = jsomwzkrza kuexlcnvio (lbknjwepks )
Positive
12 May 2022
Phase 1/2
16
drnwbvnfyo(edjayhbjmv) = sgvosutnbk nrynuahzgg (wrbbqnuczk, 3.8%)
-
12 May 2022
Phase 1/2
-
BCX9930 50mg Q12h
vsfbdxrktw(eckwijuwnf) = qmcmbcrzhr lxhvrblpmp (iawmniwlhn )
Positive
27 Oct 2021
BCX9930 100mg Q12h
vsfbdxrktw(eckwijuwnf) = bsxyzhikwo lxhvrblpmp (iawmniwlhn )
Phase 1/2
10
vxruqcjwdh(vambkrpyvz) = bdwwnrlswk lxszazkoii (mwqbxxllmq )
Positive
09 Jun 2021
Phase 1/2
6
fpbnqrvtdh(ymiktidpuc) = ujcnzsfoaj xizxzttidh (jhoqhakxmv )
-
09 Jun 2021
Phase 1
108
muzlrzpofb(riowclacgo) = None ysrxvtfhmo (azmhxtlzvi )
Positive
05 Nov 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free